Therapeutic Landscape Evolution: Technologies Shaping the Future of Pulmonary and Nasal Drug Delivery

Progress in Inhaled Drug Delivery For Non-small Cell Lung Cancer (NSCLC): A Non-invasive Pathway To Targeted Therapy

Rethinking Metabolic Peptide Delivery: Nasal and Pulmonary Routes for Incretin and Amylin Therapies

From Bench to Biologic: A Hands-On Journey to Creating a Dry Powder Inhaler or Nebulizer Product

A Programmable Aerosol Delivery Platform with Multi-Formulation Capability and High Aerosolization Rates

Ondansetron Inhalation Powder: Bioavailability and Safety Results from Phase 1 Clinical Study

Medium Chain Length Polyhydroxyalkanoate Nanoparticles for Controlled Drug Delivery to the Lung

Inhalation and Systemic Delivery of mRNA to the Lung Using a Stable Lipid Nanoparticle Platform

Evaluation of Metformin Encapsulated Rod-Shaped Iron (III) Carboxylate Biomimetic NanoMetal-Organic Frameworks as Antibacterial Immunotherapy

Characterization and Safety of Biomimetic Metal-Organic Frameworks in Macrophages

Airway Delivery of circRNA Using Pulmonary-Surfactant-Coated Lipid Nanoparticles for Cystic Fibrosis Gene Therapy

Inhalable Anti-Inflammatory psLNPs Enable Mucus Penetration and circRNA ^CFTR Delivery For Cystic Fibrosis Therapy

Direct Aerosol Administration in Preclinical Respiratory Models: Influence of the Parameters of Administration Using the Fine Mist Sprayer

Inhalable Liposomal Combination Therapy for the Treatment of Osteosarcoma Lung Metastases

Pulmonary Delivery of Ginkgetin Attenuates Lung Fibrosis in a Rat Model

Studying the Pharmacodynamic Response of the Tumor Immune Microenvironment in Osteosarcoma Lung Metastases Following Inhaled Gemcitabine Treatment